Showing results (51-60 of 182) with videos related to
Sort By:
Pageof 19
Neuroendocrinology|April 15, 2016
NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes ProgressiveMarianne Pavel, Henning Jann, Vikas Prasad, et al.Seminars in Nuclear Medicine|April 13, 2016
Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic CancerLisa Bodei, Dik J Kwekkeboom, Mark Kidd, et al.The Journal of Clinical Endocrinology and Metabolism|March 16, 2006
The functional characterization of normal and neoplastic human enterochromaffin cellsIrvin M Modlin, Mark Kidd, Roswitha Pfragner, et al.Neuroendocrinology|October 11, 2014
Neuroendocrine tumor biomarkers: current status and perspectivesIrvin M Modlin, Kjell Oberg, Andrew Taylor, et al.Cancer|March 10, 2011
Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKTBernhard Svejda, Mark Kidd, Alexander Kazberouk, et al.Medical Molecular Morphology|June 22, 2012
Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidineReidar Alexander Vigen, Mark Kidd, Irvin M Modlin, et al.Gastroenterology|May 12, 2005
Current status of gastrointestinal carcinoidsIrvin M Modlin, Mark Kidd, Igor Latich, et al.Cancer|May 14, 2008
Bronchopulmonary neuroendocrine tumorsBjorn I Gustafsson, Mark Kidd, Anthony Chan, et al.Cancer|January 29, 2008
Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptorsMark Kidd, Andrew V Schally, Roswitha Pfragner, et al.Annals of Surgery|January 25, 2006
Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor diseaseMark Kidd, Irvin M Modlin, Shrikant M Mane, et al.Pageof 19